openPR Logo
Press release

From SEO to GEO: geocentric.ai Is Redefining Visibility in the AI Era

05-19-2025 04:32 PM CET | IT, New Media & Software

Press release from: ABNewswire

From SEO to GEO: geocentric.ai Is Redefining Visibility in the AI

New startup helps businesses and creators get found, cited, and trusted by ChatGPT, Perplexity, and other AI engines
May 19, 2025 - Brooklyn NY - The way people search has changed-and so have the rules of visibility. Today's users aren't scrolling through ten blue links. They're getting full answers from AI. That's why geocentric.ai is launching a revolutionary platform that helps websites and creators show up in those answers-not just in traditional search rankings.

geocentric.ai is pioneering a bold new category called GEO: Generative Engine Optimization. Unlike SEO, which was built for search engines like Google, GEO is designed for generative platforms like ChatGPT, Bing Copilot, Google SGE, and Perplexity.ai. These engines don't just find pages-they write responses, and only cite the most trusted, high-quality sources. geocentric.ai helps you become one of them.Backed by cutting-edge research and science, the platform uses AI-driven audits, optimization tools, and content strategies proven to increase your chances of being cited by LLMs. In fact, studies show that content optimized with GEO methods-like adding statistics, quotes, and schema-can boost AI visibility by up to 40%.

"With generative engines, there are no ads, no rankings, and no way to pay your way in," said Arik Rozen, co-founder of geocentric.ai."You either show up in the answer-or you don't exist. Businesses using geocentric.ai typically see a major uptick in AI-driven traffic within 3 to 6 months. But without GEO, traffic will decline. This is the new front page of the internet-and you have to earn your place in it.

"Getting listed on AI platforms has never been easier thanks to geocentric.ai's product suite:

geoTracker lets you monitor your current AI visibility score in seconds.

geoPlanner gives you a personalized, science-backed 6-month plan to improve your visibility and get cited by major AI engines.

And for those who want full support,

geoManager is your complete GEO team-executing the plan, optimizing your content, and working 24/7 to boost your presence across platforms.

With packages starting from free all the way to full-service execution, geocentric.ai is making this new form of optimization accessible to everyone-from solopreneurs to enterprise teams. The startup's mission is simple: help real people get cited by AI, not buried beneath it.

Media Contact
Company Name: geoCentric AI LLC
Contact Person: Pinny Rozen
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=from-seo-to-geo-geocentricai-is-redefining-visibility-in-the-ai-era]
Phone: 646-995-4013
Address:1820 Ave M #1079
City: Brooklyn
State: NY
Country: United States
Website: https://geocentric.ai/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release From SEO to GEO: geocentric.ai Is Redefining Visibility in the AI Era here

News-ID: 4023855 • Views:

More Releases from ABNewswire

Small Cell Lung Cancer Pipeline Outlook Report 2025: Leading Pharma Announces Historic Progress in Treatment Development | DelveInsight
Small Cell Lung Cancer Pipeline Outlook Report 2025: Leading Pharma Announces Hi …
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline landscape. It covers the Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Small Cell Lung Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products
Type 2 Diabetes Pipeline Drugs Report 2025: Breakthrough Therapies Enter Advanced Clinical Phases | DelveInsight
Type 2 Diabetes Pipeline Drugs Report 2025: Breakthrough Therapies Enter Advance …
DelveInsight's "Type 2 Diabetes Pipeline Insight, 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Type 2 Diabetes pipeline landscape. It covers the Type 2 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Type 2 Diabetes pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Outlook Report 2025: Novel Antiviral Drugs Advance with Strong MOA Data | DelveInsight
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Outlook Report 2025: Novel A …
DelveInsight's, "Relapsed/refractory acute myeloid leukemia Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia (AML) pipeline landscape. It covers the Relapsed/Refractory Acute Myeloid Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Relapsed/Refractory Acute Myeloid Leukemia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline
Germ Cell Tumors Market: Epidemiology, Therapies, Companies - DelveInsight | Featuring Takeda, Novartis, Bristol Myers Squibb, Merck & Co., Roche, and Bayer
Germ Cell Tumors Market: Epidemiology, Therapies, Companies - DelveInsight | Fea …
In 2020, the total Germ Cell Tumor market size in the 7MM was ~USD 290 million, which is expected to increase and reach approximately USD 630 million by 2034. Emerging therapies for germ cell tumors, including Cabozantinib, are anticipated to drive significant growth in the Germ Cell Tumors market in the coming years. DelveInsight has released a new report titled "Germ Cell Tumors - Market Insights, Epidemiology, and Market Forecast 2034", offering

All 5 Releases


More Releases for GEO

Telecommunications Boom Fueling Growth In The GEO Satellite Market: Powering Inn …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the GEO Satellite Market Through 2025? In the past few years, the GEO satellite market has displayed robust growth. Projections indicate that its size will increase from $17.24 billion in 2024 to $18.15 billion in 2025, implying a compound annual growth rate (CAGR)
Commercial Geo Satellite Broadband Market Size Analysis by Application, Type, an …
According to Market Research Intellect, the global Commercial Geo Satellite Broadband market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The commercial GEO satellite broadband market is witnessing robust growth due to the rising demand for high-speed
The GEO Group, Inc. (NYSE: GEO) Investor Alert: Update in Lawsuit
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of The GEO Group, Inc. (NYSE: GEO). Investors who purchased shares of The GEO Group, Inc. (NYSE: GEO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On July 7, 2020, a lawsuit was filed against The GEO Group, Inc over alleged securities laws violations. The plaintiff
Investigation announced for Long-Term Investors in shares of The GEO Group, Inc. …
Certain directors of The Geo Group, Inc are under investigation concerning potential breaches of fiduciary duties. Investors who are current long term investors in The GEO Group, Inc. (NYSE: GEO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: GEO stocks follows a lawsuit filed against The GEO Group,
Deadline on September 7th upcoming in Lawsuit for Investors in The GEO Group, In …
A deadline is coming up on September 7, 2020 in the lawsuit filed for certain investors of The GEO Group, Inc. (NYSE: GEO) over alleged securities laws violations by The GEO Group, Inc. (NYSE: GEO). Investors who purchased shares of The GEO Group, Inc. (NYSE: GEO) have certain options and there are strict and short deadlines running. Deadline: September 7, 2020. NYSE: GEO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in shares of The GEO Group, Inc. (NYSE: GEO) over al …
An investor, who purchased shares of The GEO Group, Inc. (NYSE: GEO), filed a lawsuit over alleged violations of Federal Securities Laws by The GEO Group, Inc.. Investors who purchased shares of The GEO Group, Inc. (NYSE: GEO) have certain options and for certain investors are short and strict deadlines running. Deadline: September 7, 2020. NYSE: GEO investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On